Last $0.20 USD
Change Today 0.00 / 0.00%
Volume 263.4K
SCRC On Other Exchanges
As of 12:57 PM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

scripsamerica inc (SCRC) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/29/15 - $0.22
52 Week Low
04/15/14 - $0.08
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SCRIPSAMERICA INC (SCRC)

Related News

No related news articles were found.

scripsamerica inc (SCRC) Related Businessweek News

No Related Businessweek News Found

scripsamerica inc (SCRC) Details

ScripsAmerica, Inc. primarily develops, markets, and distributes branded over the counter (OTC) pharmaceutical products in the United States and China. It primarily focuses on the marketing, sale, and distribution of RapiMed pediatric acetaminophen products. The company was founded in 2008 and is based in Tysons Corner, Virginia.

2 Employees
Last Reported Date: 04/22/14
Founded in 2008

scripsamerica inc (SCRC) Top Compensated Officers

Founding Partner, Chief Executive Officer, Pr...
Total Annual Compensation: $120.0K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $178.0K
Compensation as of Fiscal Year 2013.

scripsamerica inc (SCRC) Key Developments

ScripsAmerica Secures $4 Million Line of Credit from Triumph Healthcare Finance

ScripsAmerica, Inc. announced that the company has secured a $4 million line of credit from Triumph Healthcare Finance. The line of credit will be used by ScripsAmerica to fund the expansion of its specialty pharmacy operations in the US and pay off its current high interest debt.

ScripsAmerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

ScripsAmerica, Inc. reported earnings results for the third quarter and nine months ended September 30, 2014. The company reported $12,817,000 in net revenue during the three months ended September 30, 2014 compared to $73,000 reported during the same period in 2013, marking an increase of $12,744,000 in quarterly revenue year on year. Gross profit for the three months ended September 30, 2014 was $11,604,000 compared to $43,000 for the same period in 2013, which is an increase of $11,561,000 or 26,886%. The revenue growth the company experienced during the third quarter was once again primarily driven by the steadily increasing sales of Main Avenue Pharmacy which is now a wholly owned subsidiary of ScripsAmerica. The company's net revenue from operations during the three quarters ended September 30, 2014 was reported as $17,342,000 compared to $452,000 over the same nine month period in 2013, marking an increase of $16,890,000 or 3,737%. For the nine month period ended September 30, 2014, gross profit for the company was approximately $15,525,343, which was 90% of its net sales as compared to a gross profit of approximately $27,783 for the same period in 2013 for an increase of approximately $15,497,560. The company's increase in gross profit from 2014 to 2013 can be attributed to its management of Main Avenue Pharmacy, which generated significant sales in the first nine months of 2014.

ScripsAmerica, Inc., Q3 2014 Earnings Call, Dec 03, 2014

ScripsAmerica, Inc., Q3 2014 Earnings Call, Dec 03, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SCRC:US $0.20 USD 0.00

SCRC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dr Reddy's Laboratories Ltd 3,363 INR +124.25
Glenmark Pharmaceuticals Ltd 719.05 INR -9.25
Henry Schein Inc $139.50 USD -1.09
Jubilant Life Sciences Ltd 175.95 INR +6.90
Ranbaxy Laboratories Ltd 709.20 INR +9.50
View Industry Companies

Industry Analysis


Industry Average

Valuation SCRC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.6x
Price/Book 26.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SCRIPSAMERICA INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at